Omeros Corporation (OMER)
What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?
Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Omeros Corporation (OMER) Q2 2026 Earnings Call Transcript
Omeros Corporation (OMER) Q2 2026 Earnings Call Transcript
Omeros Q2 Earnings Call Highlights
Omeros NASDAQ: OMER reported second-quarter net sales of $28.5 million for YARTEMLEA, its newly launched treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA, as the company generated positive operating cash flow and reduced its convertible debt after the quarter ended.
Omeros (OMER) Q2 Earnings and Revenues Beat Estimates
Omeros (OMER) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.27 per share. This compares to a loss of $0.53 per share a year ago.
Omeros stock crashes on regulatory setback: buy the dip?
Omeros Corp (OMER) stock is tumbling on Friday morning following a major regulatory setback in Europe that has caught investors off guard. Investors are bailing on OMER mostly because the European Medicines Agency's (EMA) expert panel has rejected its primary commercial asset.
Bears are Losing Control Over Omeros (OMER), Here's Why It's a 'Buy' Now
Omeros (OMER) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Omeros Q1 Earnings Call Highlights
Omeros NASDAQ: OMER reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA, its recently approved treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA.
Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript
Omeros Corporation (OMER) Q1 2026 Earnings Call Transcript
Here's Why Omeros (OMER) is a Great Momentum Stock to Buy
Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade
The consensus price target hints at a 222.8% upside potential for Omeros (OMER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 266.7% in Omeros (OMER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Omeros Corporation (OMER) Q4 2025 Earnings Call Transcript
Omeros Corporation (OMER) Q4 2025 Earnings Call Transcript
